Show simple item record

dc.contributor.authorAsamblea Mundial de la Salud, 56
dc.coverage.spatialGinebraen
dc.date.accessioned2013-04-20T15:56:08Z
dc.date.available2013-04-20T15:56:08Z
dc.date.issued2003
dc.identifier.govdocA56/16
dc.identifier.urihttps://apps.who.int/iris/handle/10665/80002
dc.description7 p.en
dc.description56ª Asamblea Mundial de la Salud, punto 14.8 del orden del día provisionalen
dc.language.isoesen
dc.publisherOrganización Mundial de la Saluden
dc.subjectEssential medicinesen
dc.subjectPharmaceutical productsen
dc.subject.meshPharmaceutical Preparationsen
dc.subject.meshDrugs, Essentialen
dc.subject.meshDrug Utilizationen
dc.subject.meshPublic Policyen
dc.subject.meshGovernment Regulationen
dc.subject.meshLegislation, Drugen
dc.subject.meshQuality Controlen
dc.subject.meshDrug Industryen
dc.titleEstrategia farmacéutica de la OMS: informe sobre los progresos realizados: informe de la Secretaríaen
dc.typeGoverning body documentsen
dc.subject.meshqualifiersupply and distributionen
dc.subject.meshqualifieradministration and dosageen
dc.subject.meshqualifierstandardsen
dc.subject.meshqualifiereconomicsen
who.relation.languageVersion10665/78242en
who.relation.languageVersion10665/81409en
who.relation.languageVersion10665/81882en


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record